Covered recipient · General Payments record
UMAR DAUD
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2019–2025
$4,945.53
- Reported across 288 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $351.02 | 12 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $213.83 | 5 |
| ABBVIE INC. | $54.09 | 3 |
| GlaxoSmithKline, LLC. | $42.06 | 2 |
| Acerta Pharma LLC | $22.65 | 1 |
| PFIZER INC. | $18.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.71 | 01/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201729608 | CMS |
| ABBVIE INC. | $17.53 | 03/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201729610 | CMS |
| ABBVIE INC. | $18.85 | 06/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201729612 | CMS |
| Amgen Inc. | $31.06 | 02/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228267441 | CMS |
| Amgen Inc. | $10.70 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227055090 | CMS |
| Amgen Inc. | $13.31 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227055088 | CMS |
| Amgen Inc. | $28.57 | 05/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228267437 | CMS |
| Amgen Inc. | $130.19 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228267439 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.65 | 02/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206235495 | CMS |
| GlaxoSmithKline, LLC. | $22.13 | 02/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191454234 | CMS |
| GlaxoSmithKline, LLC. | $19.93 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190440007 | CMS |
| PFIZER INC. | $18.39 | 06/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230814182 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.